rolf_stahel

Midatech makes two senior appointments

pharmafile | May 1, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cook, midatech, stahel 

UK-based nanomedicine firm Midatech has appointed Rolf Stahel as its chairman and Dr Craig Cook as chief operating and chief medical officer.

Stahel (pictured) has more than 40 years of experience in the pharma industry, of which 20 years were spent at chief executive and board level in public and private life science companies across Europe, the US and India. 

He was Shire’s chief executive between 1994 and 2003, and joined the firm from Wellcome (now GSK) where he spent 27 years in positions of increasing seniority. 

Advertisement

Stahel is currently the non-executive chairman of Connexios Life Sciences, an Indian drug discovery company. He has also been non-executive chairman of EUSA Pharma, Cosmo Pharmaceuticals, PowderMed and Newron Pharmaceuticals.

 

Cook has over 15 years of experience in senior management, business development and clinical product development roles in the pharma, biomedical and high technology sectors. 

Cook joins Midatech from SpaceCode Technologies, an early-stage provider of IT solutions to the healthcare industry, which he co-founded in 2005. Prior to that, he held senior management positions at Novartis and Serono International (now Merck Serono).

Cook is an advisor to Ippon Capital, the Swiss private equity firm specialising in the healthcare sector that led the latest investment round in Midatech.



 

Dr Jim Phillips, chief executive of Midatech, says: “I am very pleased to welcome Rolf to the company as our new chairman and Craig as our new COO and CMO. These two key appointments make me increasingly confident that we have the right team to translate the huge potential of our technology into significant value for our shareholders.”

Related Content

chemo-web

Midatech launch treatment to reduce chemo-induced vomiting in the US

Midatech Pharma (NASDAQ: MTP) has the full commercial launch of Zuplenz (ondansetron) in the US. …

Apple watch

Apple hails health benefits of new watch

Users of the upcoming Apple Watch will be prompted to be more active because ‘sitting …

The Gateway to Local Adoption Series

Latest content